Photodynamic Therapy
Company: Sanofi Winthrop, QLT
Approval Status: Approved January, 1996
Treatment for: esophageal cancer
Areas: Oncology
General Information
Other Useful Resources
Photodynamic Therapy (PDT) utilizes the light-activated drug, Photofrin, in combination with laser light of a specific wavelength and fiberoptic delivery devices to kill cancerous cells selectively with minimal side effects. The approval of PDT's laser system came in conjunction with the FDA approval of Photofrin to treat esophageal cancer.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
